Opioids Stuck In Pipeline Should Not Wait For REMS, National Pain Foundation Says
Products can be folded into new class-wide risk management plan once it is developed, foundation tells FDA public meeting.
Products can be folded into new class-wide risk management plan once it is developed, foundation tells FDA public meeting.